Omega Medical
Omega Medical is a Calabasas, CA-based medical technology company founded in 2023 that sells advanced wound care products — including its APIS® Manuka Honey skin substitute, other skin substitutes and biologics, DME supplies, and aesthetic products — directly to wound care specialists and healthcare professionals.
- Company typePrivate
- Founded-
- HeadquartersNot specified, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Omega Medical does
Omega Medical is a Calabasas, California-based medical technology company founded in 2023 that supplies wound care, durable medical equipment (DME), and aesthetic products to healthcare professionals. Its stated focus is regenerative wound care, anchored by its flagship APIS® skin substitute — a proprietary formulation incorporating Manuka Honey — alongside a broader portfolio of skin substitutes and biologics, DME supplies for wound care, and aesthetic products intended to support post-procedure recovery and skin health. The company's mission is framed as supporting patient treatment until chronic wounds become a thing of the past, and its vision is to connect healthcare teams with innovative regenerative products and support services.
Operationally, Omega Medical runs a sales-led, direct-engagement go-to-market: products are sold directly to wound care specialists, healthcare teams, and clinical professionals, with the corporate website as the primary digital surface and a single phone number ((213) 254-9333) for inbound inquiries. Pricing is not publicly disclosed; customers are directed to contact the company. Revenue mechanics are described as one-time license/sale of skin substitutes and biologics and hardware sales for DME and aesthetic products. The company is privately held, has approximately 10 employees, has no disclosed funding rounds, no parent company, and no publicly named management team, customers, or regulatory certifications in the source material.
Omega Medical firmographics
Firmographics- Name
- Omega Medical
- Legal name
- Omega Medical
- Website
- https://omegamedical.co
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Omega Medical is a Calabasas, CA-based medical technology company founded in 2023 that sells advanced wound care products — including its APIS® Manuka Honey skin substitute, other skin substitutes and biologics, DME supplies, and aesthetic products — directly to wound care specialists and healthcare professionals.
- Ownership category
- akta.pro rank
Omega Medical industry classification
Industry- Product category
- Wound Care Medical Products
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
- akta.pro secondary industry
- Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where Omega Medical is headquartered
LocationHeadquarters
- HQ city
- Not specified
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Omega Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Skin Substitutes and Biologics: Sale of advanced skin substitutes and biologics to healthcare providers and wound care specialists. These products support the body's natural healing process for chronic wounds.
- DME Supplies (Durable Medical Equipment): Sale of wound care supplies and DME products to healthcare professionals and patients, featuring new technologies and programs aimed at improving wound care outcomes.
- Aesthetic Products: Sale of advanced aesthetic products designed to support superior outcomes and faster recovery after procedures, targeting skin health and beauty applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Omega Medical product offering
Product offeringCore offering
Omega Medical provides advanced skin substitutes and biologics (including its proprietary APIS® skin substitute with Manuka Honey), durable medical equipment (DME) wound care supplies, and aesthetic products to healthcare professionals. The portfolio is designed to support chronic wound treatment, post-procedure recovery, and skin health applications, sold directly to wound care specialists and medical practices.
Product overview
Omega Medical is a provider of advanced medical technology and unique products focused on wound care. Their portfolio includes APIS® (a skin substitute with Manuka Honey), advanced skin substitutes and biologics, durable medical equipment (DME) supplies, and aesthetic products. These offerings are designed to support healthcare professionals in addressing chronic wounds, promoting faster healing, and delivering superior patient outcomes.
Differentiator
Problem solved
Functional benefit
Brands
- APIS®: Skin Sub with Manuka Honey - Advanced skin substitute product
Products and services
- APIS® Skin Substitute with Manuka Honey
- Skin Substitutes and Biologics
- DME Supplies
- Aesthetic Products
Companies that use Omega Medical
Customer profileSegments1 record
Ideal customer profiles1 record
Omega Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Omega Medical partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
Omega Medical competitors and assessment
Company assessmentDirect peers
- Organogenesis: Organogenesis is a leading US manufacturer of advanced wound care and skin substitute products (e.g., Apligraf, Dermagraft). It is the most directly comparable peer to Omega Medical given overlapping focus on biologic skin substitutes sold to wound care specialists.
- Integra LifeSciences: Integra LifeSciences offers regenerative wound care technologies including Integra Dermal Regeneration Template and skin substitute products. It is a direct competitor in advanced wound care biologics and shares Omega Medical's hospital and specialty clinic sales motion.
- MiMedx Group: MiMedx develops and markets regenerative skin and soft-tissue allografts (e.g., EpiFix, AmnioFix) used in wound care and surgical recovery. It directly competes with Omega Medical's APIS® and broader skin substitute portfolio in the chronic wound care channel.
- Amniox Medical (TissueTech): Amniox Medical / TissueTech markets biologic wound healing and surgical recovery products derived from amniotic membrane (e.g., CLARIX, NEOX). It is a direct peer in regenerative skin substitute and post-procedure tissue repair offerings.
Broad incumbents
- Coloplast: Coloplast is a global wound care and ostomy manufacturer with advanced wound care dressings and skin management products. It is a broad incumbent competitor in the same wound care provider channel as Omega Medical.
- Smith+Nephew: Smith+Nephew is a global medical device incumbent with a large advanced wound care portfolio (e.g., PICO, ALLEVYN, skin substitute offerings). It competes broadly with Omega Medical in wound care, though it is not focused exclusively on skin substitutes like Omega.
- 3M Health Care (Solventum): Solventum (spun off from 3M Health Care) is a broad medical incumbent with a significant advanced wound care portfolio. It competes with Omega Medical in DME supplies and certain wound care categories, though it operates at vastly larger scale.
- Convatec: Convatec is a major wound care and ostomy player (e.g., AQUACEL) operating across advanced dressings and skin/soft-tissue management. It overlaps with Omega Medical's DME supplies and skin substitute categories as a broad incumbent.
Emerging players
- PolyNovo: PolyNovo is a smaller regenerative medicine company focused on dermal regeneration and wound care (e.g., NovoSorb BTM). It is comparable to Omega Medical as a niche, growth-stage peer in advanced wound and skin regeneration.
- Bioventus: Bioventus offers orthobiologics and wound care solutions including skin substitute and soft tissue repair products following its Misonix acquisition. It is comparable to Omega Medical as a smaller, growth-stage biologics player in adjacent regenerative categories.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Omega Medical social profiles
Digital presenceOmega Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Omega Medical leadership team
Management profileNumber of profiles
Omega Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Omega Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Omega Medical
What does Omega Medical do?
Omega Medical provides advanced skin substitutes and biologics (including its proprietary APIS® skin substitute with Manuka Honey), durable medical equipment (DME) wound care supplies, and aesthetic products to healthcare professionals. The portfolio is designed to support chronic wound treatment, post-procedure recovery, and skin health applications, sold directly to wound care specialists and medical practices.
Is Omega Medical a public or private company?
Omega Medical is a private company. It is classified as unknown and is currently operating.
When was Omega Medical founded?
Omega Medical was founded in -1. It employs 1 to 10 people.
Where is Omega Medical based?
Omega Medical is headquartered in Not specified, United States, in the North America region.
How does Omega Medical make money?
Three revenue lines are on record. Skin Substitutes and Biologics are the primary driver. The others are DME Supplies (Durable Medical Equipment) and aesthetic Products.
Who are Omega Medical's main competitors?
Direct peers on record are Organogenesis, Integra LifeSciences, MiMedx Group and Amniox Medical (TissueTech). Broad incumbents are Coloplast, Smith+Nephew, 3M Health Care (Solventum) and Convatec. Emerging players are PolyNovo and Bioventus.
Does Omega Medical have an API?
No public API is recorded for Omega Medical.
What industry is Omega Medical in?
Omega Medical's product category is Wound Care Medical Products. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 3391 and its SIC code is 3841.